Sickle cell disease in Africa: a neglected cause of early childhood mortality

Scott D Grosse, Isaac Odame, Hani K Atrash, Djesika D Amendah, Frédéric B Piel, Thomas N Williams, Scott D Grosse, Isaac Odame, Hani K Atrash, Djesika D Amendah, Frédéric B Piel, Thomas N Williams

Abstract

Sickle cell disease (SCD) is common throughout much of sub-Saharan Africa, affecting up to 3% of births in some parts of the continent. Nevertheless, it remains a low priority for many health ministries. The most common form of SCD is caused by homozygosity for the β-globin S gene mutation (SS disease). It is widely believed that this condition is associated with very high child mortality, but reliable contemporary data are lacking. We have reviewed available African data on mortality associated with SS disease from published and unpublished sources, with an emphasis on two types of studies: cross-sectional population surveys and cohort studies. We have concluded that, although current data are inadequate to support definitive statements, they are consistent with an early-life mortality of 50%-90% among children born in Africa with SS disease. Inclusion of SCD interventions in child survival policies and programs in Africa could benefit from more precise estimates of numbers of deaths among children with SCD. A simple, representative, and affordable approach to estimate SCD child mortality is to test blood specimens already collected through large population surveys targeting conditions such as HIV, malaria, and malnutrition, and covering children of varying ages. Thus, although there is enough evidence to justify investments in screening, prophylaxis, and treatment for African children with SCD, better data are needed to estimate the numbers of child deaths preventable by such interventions and their cost effectiveness.

Copyright © 2011 American Journal of Preventive Medicine. All rights reserved.

Figures

Figure 1
Figure 1
Map of the distribution of the βS gene in Africa Note: The map is based on representative indigenous population samples and is adapted from Figure 1b in Piel et al. The figure shows the global distribution of the sickle cell gene and geographic confirmation of the malaria hypothesis.
Figure 2
Figure 2
Prevalence of Hb SS by age among children in three African studies Note: The studies are Fleming et al. (Garki, Nigeria), Williams et al. (Kilifi, Kenya), and Barclay (Zambia). Hb SS, sickle cell anemia

References

    1. Rees D.C., Williams T.N., Gladwin M.T. Sickle-cell disease. Lancet. 2010;376:2018–2031.
    1. Serjeant G.R. Mortality from sickle cell disease in Africa. BMJ. 2005;330:432–433.
    1. Makani J., Williams T.N., Marsh K. Sickle cell disease in Africa: burden and research priorities. Ann Trop Med Parasitol. 2007;101:3–14.
    1. Diallo D.A. Sickle cell disease in Africa: current situation and strategies for improving the quality and duration of survival [in French] Bull Acad Natl Med. 2008;192:1361–1372.
    1. Weatherall D.J. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010;115:4331–4336.
    1. Weatherall D.J., Clegg J.B. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79:704–712.
    1. Obaro S. Pneumococcal infections and sickle cell disease in Africa: does absence of evidence imply evidence of absence? Arch Dis Child. 2009;94:713–716.
    1. Makani J., Cox S.E., Soka D. Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania. PLoS ONE. 2011;6:e14699.
    1. Williams T.N., Obaro S.K. Sickle cell disease and malaria morbidity: a tale with two tails. Trends Parasitol. 2011;27(7):315–320.
    1. Fleming A.F., Storey J., Molineaux L., Iroko E.A., Attai E.D. Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. Ann Trop Med Parasitol. 1979;73:161–172.
    1. Molineaux L., Fleming A.F., Cornille-Brogger R., Kagan I., Storey J. Abnormal haemoglobins in the Sudan savanna of Nigeria. III. Malaria, immunoglobulins and antimalarial antibodies in sickle cell disease. Ann Trop Med Parasitol. 1979;73:301–310.
    1. Fleming A.F. The presentation, management and prevention of crisis in sickle cell disease in Africa. Blood Rev. 1989;3:18–28.
    1. Yanni E., Grosse S.D., Yang Q., Olney R.S. Trends in pediatric sickle cell disease-related mortality in the United States, 1983–2002. J Pediatr. 2009;154:541–545.
    1. Quinn C.T., Rogers Z.R., McCavit T.L., Buchanan G.R. Improved survival of children and adolescents with sickle cell disease. Blood. 2010;115:3447–3452.
    1. Powars D., Overturf G., Weiss J., Lee S., Chan L. Pneumococcal septicemia in children with sickle cell anemia. Changing trend of survival. JAMA. 1981;245:1839–1842.
    1. Vichinsky E., Hurst D., Earles A., Kleman K., Lubin B. Newborn screening for sickle cell disease: effect on mortality. Pediatrics. 1988;81:749–755.
    1. King L., Fraser R., Forbes M., Grindley M., Ali S., Reid M. Newborn sickle cell disease screening: the Jamaican experience (1995–2006) J Med Screen. 2007;14:117–122.
    1. Rahimy M.C., Gangbo A., Ahouignan G., Alihonou E. Newborn screening for sickle cell disease in the Republic of Benin. J Clin Pathol. 2009;62:46–48.
    1. Grosse S.D., Olney R.S., Baily M.A. The cost effectiveness of universal versus selective newborn screening for sickle cell disease in the US and the UK: a critique. Appl Health Econ Health Policy. 2005;4:239–247.
    1. Grosse S.D. Assessing the clinical utility of newborn screening. In: Khoury M., Gwinn M., Higgins J., Ioannidis J., Little J., editors. Human genome epidemiology. 2nd ed. Oxford University Press; New York NY: 2009.
    1. United Nations press office Press conference on raising awareness of sickle-cell anaemia. June 2009.
    1. Modell B., Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86:480–487.
    1. World Health Organization Regional Office for Africa . WHO; Geneva, Switzerland: 22 June 2010. Sickle-cell disease: a strategy for the WHO African Region: Report of the Regional Director. AFR/RC60/8.
    1. Piel F.B., Patil A.P., Howes R.E. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun. 2010;1:104.
    1. McAuley C.F., Webb C., Makani J. High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya. Blood. 2010;116:1663–1668.
    1. Tshilolo L., Kafando E., Sawadogo M. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies. Public Health. 2008;122:933–941.
    1. Christianson A.L., Howson C.P., Modell B. March of Dimes Birth Defects Foundation; White Plains NY: 2006. March of Dimes global report on birth defects: the hidden toll of dying and disabled children.
    1. Ebrahim S.H., Khoja T.A., Elachola H., Atrash H.K., Memish Z., Johnson A. Children who come and go: the state of sickle cell disease in resource-poor countries. Am J Prev Med. 2010;38(4S):S568–S570.
    1. Edington G.M., Lehmann H. A case of sickle cell haemoglobin C disease and a survey of haemoglobin C incidence in West Africa. Trans R Soc Trop Med Hyg. 1954;48:332–336.
    1. Vandepitte J. Quantitative and genetic aspects of sickle cell anemia in Leopoldsville [in French] Ann Soc Belg Med Trop. 1954;34:501–516.
    1. Lambotte-Legrand J., Lambotte-Legrand C. Prognosis of sickle cell anemia in Belgian Congo; based on 300 cases and 150 deaths [in French] Ann Soc Belg Med Trop ( 1955;35(1920):53–57.
    1. Lehmann H., Raper A.B. Maintenance of high sickling rate in an African community. Br Med J. 1956;2:333–336.
    1. Barclay G.P., Huntsman R.G., Robb A. Population screening of young children for sickle cell anaemia in Zambia. Trans R Soc Trop Med Hyg. 1970;64:733–739.
    1. Jacob G.F. A study of the survival rate of cases of sickle-cell anaemia. Br Med J. 1957;1:738–739.
    1. Bernstein S.C., Bowman J.E., Kaptue Noche L. Population studies in Cameroon: hemoglobin S, glucose-6-phosphate dehydrogenase deficiency and falciparum malaria. Hum Hered. 1980;30:251–258.
    1. Akinyanju O.O. A profile of sickle cell disease in Nigeria. Ann N Y Acad Sci. 1989;565:126–136.
    1. Aluoch J.R., Aluoch L.H. Survey of sickle disease in Kenya. Trop Geogr Med. 1993;45:18–21.
    1. Allison A.C. The sickle-cell and haemoglobin C genes in some African populations. Ann Hum Genet. 1956;21:67–89.
    1. Labie D., Richin C., Pagnier J., Gentilini M., Nagel R.L. Hemoglobins S and C in Upper Volta. Hum Genet. 1984;65:300–302.
    1. Simpore J., Pignatelli S., Barlati S., Musumeci S. Modification in the frequency of Hb C and Hb S in Burkina Faso: an influence of migratory fluxes and improvement of patient health care. Hemoglobin. 2002;26:113–120.
    1. Williams T.N., Uyoga S., Macharia A. Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study. Lancet. 2009;374:1364–1370.
    1. Williams T.N., Mwangi T.W., Wambua S. Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. J Infect Dis. 2005;192:178–186.
    1. Aidoo M., Terlouw D.J., Kolczak M.S. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet. 2002;359:1311–1312.
    1. Kreuels B., Kreuzberg C., Kobbe R. Differing effects of HbS and HbC traits on uncomplicated falciparum malaria, anemia, and child growth. Blood. 2010;115:4551–4558.
    1. Masmas T.N., Garly M.L., Lisse I.M. Inherited hemoglobin disorders in Guinea-Bissau, West Africa: a population study. Hemoglobin. 2006;30:355–364.
    1. Barclay G.P. Sickle cell anaemia in Zambia. Trans R Soc Trop Med Hyg. 1971;65:529–530.
    1. Danquah I., Ziniel P., Eggelte T.A., Ehrhardt S., Mockenhaupt F.P. Influence of haemoglobins S and C on predominantly asymptomatic Plasmodium infections in northern Ghana. Trans R Soc Trop Med Hyg. 2010;104:713–719.
    1. Desai M.R., Terlouw D.J., Kwena A.M. Factors associated with hemoglobin concentrations in pre-school children in western Kenya: cross-sectional studies. Am J Trop Med Hyg. 2005;72:47–59.
    1. Allen S.J., Bennett S., Riley E.M. Morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in children with sickle cell trait in The Gambia. Trans R Soc Trop Med Hyg. 1992;86:494–498.
    1. Cox S.E., Doherty C.P., Atkinson S.H. Haptoglobin genotype, anaemia and malaria in Gambian children. Trop Med Int Health. 2008;13:76–82.
    1. Sarr J.B., Pelleau S., Toly C. Impact of red blood cell polymorphisms on the antibody response to Plasmodium falciparum in Senegal. Microbes Infect. 2006;8:1260–1268.
    1. Saurin W. Natural selection study in small size populations. The drepanocytosis case in Madinka and Bedik from the Kedougou region (Eastern Senegal) [in French] Bull Mém Soc d'Anthrop Paris. 1984;14:37–56.
    1. Athale U.H., Chintu C. Clinical analysis of mortality in hospitalized Zambian children with sickle cell anaemia. East Afr Med J. 1994;71:388–391.
    1. Tshilolo L., Aissi L.M., Lukusa D. Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns. J Clin Pathol. 2009;62:35–38.
    1. Munyanganizi R., Cotton F., Vertongen F., Gulbis B. Red blood cell disorders in Rwandese neonates: screening for sickle cell disease and glucose-6-phosphate dehydrogenase deficiency. J Med Screen. 2006;13:129–131.
    1. Mutesa L., Boemer F., Ngendahayo L. Neonatal screening for sickle cell disease in Central Africa: a study of 1825 newborns with a new enzyme-linked immunosorbent assay test. J Med Screen. 2007;14:113–116.
    1. Ohene-Frempong K., Oduro J., Tetteh H., Nkrumah F. Screening newborns for sickle cell disease in Ghana. Pediatrics. 2008;121:S120–S121.
    1. United Nations . United Nations; New York NY: 2000. United Nations Millennium Declaration, resolution 55/2.
    1. World Health Organization . World Health Organization; Geneva, Switzerland: 17–19 May 2006. Report of a joint WHO–March of Dimes meeting: management of birth defects and haemoglobin disorders.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren